TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets
出版年份 2017 全文链接
标题
TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets
作者
关键词
-
出版物
mAbs
Volume 9, Issue 4, Pages 603-614
出版商
Informa UK Limited
发表日期
2017-03-09
DOI
10.1080/19420862.2017.1302630
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antibody-drug conjugates—an emerging class of cancer treatment
- (2016) Nikolaos Diamantis et al. BRITISH JOURNAL OF CANCER
- New developments for antibody-drug conjugate-based therapeutic approaches
- (2016) Bart ECG de Goeij et al. CURRENT OPINION IN IMMUNOLOGY
- Opportunities and challenges for TCR mimic antibodies in cancer therapy
- (2016) Aaron Y. Chang et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Intracellular recycling and cross-presentation by MHC class I molecules
- (2016) Peter van Endert IMMUNOLOGICAL REVIEWS
- Solid-Phase Synthesis of Duocarmycin Analogues and the Effect of C-Terminal Substitution on Biological Activity
- (2015) Michael J. Stephenson et al. JOURNAL OF ORGANIC CHEMISTRY
- The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers
- (2015) M. M. C. van der Lee et al. MOLECULAR CANCER THERAPEUTICS
- Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody–Drug Conjugate SYD985
- (2015) Ronald C. Elgersma et al. MOLECULAR PHARMACEUTICS
- Current ADC Linker Chemistry
- (2015) Nareshkumar Jain et al. PHARMACEUTICAL RESEARCH
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Intracellular Transport Routes for MHC I and Their Relevance for Antigen Cross-Presentation
- (2015) Aimé Cézaire Adiko et al. Frontiers in Immunology
- T cell receptor mimic antibodies for cancer therapy
- (2015) Leonid Dubrovsky et al. OncoImmunology
- Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
- (2014) N. Veomett et al. CLINICAL CANCER RESEARCH
- Preclinical Profile of the HER2-Targeting ADC SYD983/SYD985: Introduction of a New Duocarmycin-Based Linker-Drug Platform
- (2014) W. Dokter et al. MOLECULAR CANCER THERAPEUTICS
- Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells
- (2014) Giovanna Bossi et al. OncoImmunology
- Pathways of Antigen Processing
- (2013) Janice S. Blum et al. Annual Review of Immunology
- Robo4 is an effective tumor endothelial marker for antibody-drug conjugates based on the rapid isolation of the anti-Robo4 cell-internalizing antibody
- (2013) M. Yoshikawa et al. BLOOD
- Antibody–drug conjugates: current status and future directions
- (2013) Heidi L. Perez et al. DRUG DISCOVERY TODAY
- Targeting HER2+ breast cancer cells: Lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticles
- (2013) Shawn C. Owen et al. JOURNAL OF CONTROLLED RELEASE
- Antitumor Activity of a Monoclonal Antibody Targeting Major Histocompatibility Complex Class I–Her2 Peptide Complexes
- (2013) Rinki Jain et al. JNCI-Journal of the National Cancer Institute
- Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates
- (2013) Michael Ritchie et al. mAbs
- Maturing antibody–drug conjugate pipeline hits 30
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Cathepsin B Inhibition Limits Bone Metastasis in Breast Cancer
- (2012) N. P. Withana et al. CANCER RESEARCH
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers
- (2011) R. Ghosh et al. CANCER RESEARCH
- Efficient induction of a Her2-specific anti-tumor response by dendritic cells pulsed with a Hsp70L1–Her2341–456 fusion protein
- (2011) Qiang Fu et al. Cellular & Molecular Immunology
- An Antibody-Drug Conjugate Targeting the Endothelin B Receptor for the Treatment of Melanoma
- (2011) J. Asundi et al. CLINICAL CANCER RESEARCH
- TCR-like Biomolecules Target Peptide/MHC Class I Complexes on the Surface of Infected and Cancerous Cells
- (2011) Jon A. Weidanz et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Early endosomal rerouting of major histocompatibility class I conformers
- (2011) Gordana Blagojević Zagorac et al. JOURNAL OF CELLULAR PHYSIOLOGY
- TCR Mimic Monoclonal Antibodies Induce Apoptosis of Tumor Cells via Immune Effector-Independent Mechanisms
- (2011) B. Verma et al. JOURNAL OF IMMUNOLOGY
- An HLA-Presented Fragment of Macrophage Migration Inhibitory Factor Is a Therapeutic Target for Invasive Breast Cancer
- (2011) O. Hawkins et al. JOURNAL OF IMMUNOLOGY
- In Vitro and In Vivo Responses of Advanced Prostate Tumors to PSMA ADC, an Auristatin-Conjugated Antibody to Prostate-Specific Membrane Antigen
- (2011) X. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties
- (2009) Bhavna Verma et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intracellular Assembly and Trafficking of MHC Class I Molecules
- (2009) Julie G. Donaldson et al. TRAFFIC
- Antitumor Activity of Immunotoxins with T-Cell Receptor-like Specificity against Human Melanoma Xenografts
- (2008) E. Klechevsky et al. CANCER RESEARCH
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
- (2008) G. D. Lewis Phillips et al. CANCER RESEARCH
- Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies
- (2008) Malka Epel et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- How a T Cell Receptor-like Antibody Recognizes Major Histocompatibility Complex-bound Peptide
- (2008) Tatiana Mareeva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started